Fluorescence in situ hybridization for rapid identification of Achromobacter xylosoxidans and Alcaligenes faecalis recovered from cystic fibrosis patients

Journal of Clinical Microbiology

Volumn 44, Issue 9, 2006, Pages 3415-3417

  Wellinghausen, Nele ^a   Wirths, Beate ^a   Poppert, Sven ^a  

^a UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACHROMOBACTER XYLOSOXIDANS; ALCALIGENES FAECALIS; ARTICLE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BRONCHUS SECRETION; CYSTIC FIBROSIS; EARLY DIAGNOSIS; FERMENTATION; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; NONHUMAN; PRIORITY JOURNAL; RELIABILITY; RESPIRATORY TRACT INFECTION; SENSITIVITY AND SPECIFICITY;

ACHROMOBACTER DENITRIFICANS; ALCALIGENES FAECALIS; BACTERIAL TYPING TECHNIQUES; CYSTIC FIBROSIS; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; SENSITIVITY AND SPECIFICITY; TIME FACTORS;

ACHROMOBACTER XYLOSOXIDANS; ALCALIGENES FAECALIS;

EID: 33748784909     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.00508-06     Document Type: Article

References (31)

1. Aisenberg, G., K. V. Rolston, and A. Safdar. 2004. Bacteremia caused by Achromobacter and Alcaligenes species in 46 patients with cancer (1989-2003). Cancer 101:2134-2140.
2. Altschul, S. F., T. L. Madden, A. A. Schaffer, J. Zhang, Z. Zhang, W. Miller, and D. J. Lipman. 1997. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 25:3389-3402.
3. Amann, R. I., B. J. Binder, R. J. Olson, S. W. Chisholm, R. Devereux, and D. A. Stahl. 1990. Combination of 16S rRNA-targeted oligonucleotide probes with flow cytometry for analyzing mixed microbial populations. Appl. Environ. Microbiol. 56:1919-1925.
4. Amann, R. I., W. Ludwig, and K. H. Schleifer. 1995. Phylogenetic identification and in situ detection of individual microbial cells without cultivation. Microbiol. Rev. 59:143-169.
5. Burns, J. L., J. Emerson, J. R. Stapp, D. L. Yim, J. Krzewinski, L. Louden, B. W. Ramsey, and C. R. Clausen. 1998. Microbiology of sputum from patients at cystic fibrosis centers in the United States. Clin. Infect. Dis. 27:158-163.
6. Coenye, T., J. Goris, T. Spilker, P. Vandamme, and J. J. LiPuma. 2002. Characterization of unusual bacteria isolated from respiratory secretions of cystic fibrosis patients and description of Inquilinus limosus gen. nov., sp. nov. J. Clin. Microbiol. 40:2062-2069.
7. El Shahawy, M. A., D. Kim, and M. F. Gadallah. 1998. Peritoneal dialysis-associated peritonitis caused by Alcaligenes xylosoxidans. Am. J. Nephrol. 18:452-455.
8. Ferroni, A., I. Sermet-Gaudelus, E. Abachin, G. Quesne, G. Lenoir, P. Berche, and J. L. Gaillard. 2002. Use of 16S rRNA gene sequencing for identification of nonfermenting gram-negative bacilli recovered from patients attending a single cystic fibrosis center. J. Clin. Microbiol. 40:3793-3797.
9. Gomez-Cerezo, J., I. Suarez, J. J. Rios, P. Pena, M. J. Garcia de Miguel, M. de Jose, O. Monteagudo, P. Linares, A. Barbado-Cano, and J. J. Vazquez. 2003. Achromobacter xylosoxidans bacteremia: a 10-year analysis of 54 cases. Eur. J. Clin. Microbiol. Infect. Dis. 22:360-363.
10. Hogardt, M., K. Trebesius, A. M. Geiger, M. Hornef, J. Rosenecker, and J. Heesemann. 2000. Specific and rapid detection by fluorescent in situ hybridization of bacteria in clinical samples obtained from cystic fibrosis patients. J. Clin. Microbiol. 38:818-825.
11. Kanellopoulou, M., S. Pournaras, H. Iglezos, N. Skarmoutsou, E. Papafrangas, and A. N. Maniatis. 2004. Persistent colonization of nine cystic fibrosis patients with an Achromobacter (Alcaligenes) xylosoxidans clone. Eur. J. Clin. Microbiol. Infect. Dis. 23:336-339.
12. Klinger, J. D., and M. J. Thomassen. 1985. Occurrence and antimicrobial susceptibility of gram-negative nonfermentative bacilli in cystic fibrosis patients. Diagn. Microbiol. Infect. Dis. 3:149-158.
13. Krzewinski, J. W., C. D. Nguyen, J. M. Foster, and J. L. Burns. 2001. Use of random amplified polymorphic DNA PCR to examine epidemiology of Stenotrophomonas maltophilia and Achromobacter (Alcaligenes) xylosoxidans from patients with cystic fibrosis. J. Clin. Microbiol. 39:3597-3602.
14. Lambiase, A., V. Raia, M. Del Pezzo, A. Sepe, V. Carnovale, and F. Rossano. 2006. Microbiology of airway disease in a cohort of patients with cystic fibrosis. BMC Infect. Dis. 6:4.
15. Liu, L., T. Coenye, J. L. Burns, P. W. Whitby, T. L. Stull, and J. J. LiPuma. 2002. Ribosomal DNA-directed PCR for identification of Achromobacter (Alcaligenes) xylosoxidans recovered from sputum samples from cystic fibrosis patients. J. Clin. Microbiol. 40:1210-1213.
16. Manz, W. R. Amann, W. Ludwig, M. Wagner, and K. H. Schleifer. 1992. Phylogenetic oligodeoxynucleotide probes for the major subclasses of proteobacteria: problems and solutions. Syst. Appl. Microbiol. 1:593-600.
17. McMenamin, J. D., T. M. Zaccone, T. Coenye, P. Vandamme, and J. J. LiPuma. 2000. Misidentification of Burkholderia cepacia in US cystic fibrosis treatment centers: an analysis of 1,051 recent sputum isolates. Chest 117:1661-1665.
18. Moissenet, D., A. Baculard, M. Valcin, V. Marchand, G. Tournier, A. Garbarg-Chenon, and H. Vu-Thien. 1997. Colonization by Alcaligenes xylosoxidans in children with cystic fibrosis: a retrospective clinical study conducted by means of molecular epidemiological investigation. Clin. Infect. Dis. 24:274-275.
19. Namnyak, S. S., B. Holmes, and S. E. Fathalla. 1985. Neonatal meningitis caused by Achromobacter xylosoxidans. J. Clin. Microbiol. 22:470-471.
20. Poppert, S., A. Essig, B. Stoehr, A. Steingruber, B. Wirths, S. Juretschko, U. Reischl, and N. Wellinghausen. 2005. Rapid diagnosis of bacterial meningitis by real-time PCR and fluorescence in situ hybridization. J. Clin. Microbiol. 43:3390-3397.
21. Ramos, J. M., R. Fernandez-Roblas, P. Garcia-Ruiz, and F. Soriano. 1995. Meningitis caused by Alcaligenes (Achromobacter) xylosoxidans associated with epidural catheter. Infection 23:395-396.
22. Saiman, L., Y. Chen, S. Tabibi, P. San Gabriel, J. Zhou, Z. Liu, L. Lai, and S. Whittier. 2001. Identification and antimicrobial susceptibility of Alcaligenes xylosoxidans isolated from patients with cystic fibrosis. J. Clin. Microbiol. 39:3942-3945.
23. Shelly, D. B., T. Spilker, E. J. Gracely, T. Coenye, P. Vandamme, and J. J. LiPuma. 2000. Utility of commercial systems for identification of Burkholderia cepacia complex from cystic fibrosis sputum culture. J. Clin. Microbiol. 38:3112-3115.
24. Tan, K., S. P. Conway, K. G. Brownlee, C. Etherington, and D. G. Peckham. 2002. Alcaligenes infection in cystic fibrosis. Pediatr. Pulmonol. 34:101-104.
25. Tang, S., C. C. Cheng, K. C. Tse, F. K. Li, B. Y. Choy, T. M. Chan, and K. N. Lai. 2001. CAPD-associated peritonitis caused by Alcaligenes xylosoxidans sp. xylosoxidans. Am. J. Nephrol. 21:502-506.
26. Tsay, R. W., L. C. Lin, C. S. Chiou, J. C. Liao, C. H. Chen, C. E. Liu, and T. G. Young. 2005. Alcaligenes xylosoxidans bacteremia: clinical features and microbiological characteristics of isolates. J. Microbiol. Immunol. Infect. 38:194-199.
27. Van Daele, S., R. Verhelst, G. Claeys, G. Verschraegen, H. Franckx, L. Van Simaey, C. de Ganck, F. De Baets, and M. Vaneechoutte. 2005. Shared genotypes of Achromobacter xylosoxidans strains isolated from patients at a cystic fibrosis rehabilitation center. J. Clin. Microbiol. 43:2998-3002.
28. Vandamme, P., M. Heyndrickx, M. Vancanneyt, B. Hoste, P. De Vos, E. Falsen, K. Kersters, and K. H. Hinz. 1996. Bordetella trematum sp. nov., isolated from wounds and ear infections in humans, and reassessment of Alcaligenes denitrificans Ruger and Tan 1983. Int. J. Syst. Bacteriol. 46:849-858.
29. van Pelt, C., C. M. Verduin, W. H. Goessens, M. C. Vos, B. Tummler, C. Segonds, F. Reubsaet, H. Verbrugb, and A. van Belkum. 1999. Identification of Burkholderia spp. in the clinical microbiology laboratory: comparison of conventional and molecular methods. J. Clin. Microbiol. 37:2158-2164.
30. Wellinghausen, N., J. Kothe, B. Wirths, A. Sigge, and S. Poppert. 2005. Superiority of molecular techniques for identification of gram-negative, oxidase-positive rods, including morphologically nontypical Pseudomonas aeruginosa, from patients with cystic fibrosis. J. Clin. Microbiol. 43:4070-4075.
31. Yabuuchi, E., Y. Kawamura, Y. Kosako, and T. Ezaki. 1998. Emendation of genus Achromobacter and Achromobacter xylosoxidans (Yabuuchi and Yano) and proposal of Achromobacter ruhlandii (Packer and Vishniac) comb, nov., Achromobacter piechaudii (Kiredjian et al.) comb, nov., and Achromobacter xylosoxidans subsp. denitrificans (Ruger and Tan) comb. nov. Microbiol. Immunol. 42:429-438.